Watchlist Price Alert

Syros Pharmaceuticals Inc... (SYRS)

NASDAQ: SYRS · Real-Time Price · USD

0.03

-0.00 (-3.23%)

At close: May 06, 2025, 3:15 PM

0.03

0.00%

After-hours: May 06, 2025, 03:15 PM EDT

Syros Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	139.53M	167.47M	92.3M	173.98M	41.44M	49.89M	32.2M	58.59M
Short-Term Investments	n/a	34.84M	38.07M	n/a	49.98M	49.79M	39.84M	25M
Long-Term Investments	n/a	3.09M	13.04M	3.09M	3.09M	290K	290K	483K
Other Long-Term Assets	3.71M	5.35M	6.03M	1.97M	490K	881K	1.1M	482K
Receivables	n/a	1.69M	2.98M	2.33M	20.16M	n/a	n/a	867K
Inventory	n/a	1.00	n/a	1.00	290K	n/a	n/a	1.00
Other Current Assets	5.45M	7.39M	n/a	n/a	290K	638K	193K	1.05M
Total Current Assets	144.98M	211.39M	136.59M	178.56M	114.51M	101.73M	73.16M	85.51M
Property-Plant & Equipment	19.48M	24.66M	27.29M	29.64M	31.89M	3.86M	3.94M	4.85M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	23.19M	33.09M	46.35M	34.69M	35.47M	5.03M	5.33M	5.82M
Total Assets	168.17M	244.49M	182.94M	213.25M	149.98M	106.77M	78.49M	91.32M
Account Payables	11.54M	6.41M	3.69M	3.6M	5.85M	3.31M	2.28M	2.42M
Deferred Revenue	n/a	4.33M	10.18M	12.21M	5.74M	1.93M	355K	550K
Short-Term Debt	6.67M	2.07M	2.01M	1.73M	1.28M	9K	47K	168K
Other Current Liabilities	6.99M	7.37M	7.27M	3.99M	5.19M	11.29M	7.54M	4.36M
Total Current Liabilities	36.68M	30.78M	31.51M	28.62M	23.52M	19.53M	12.41M	9.57M
Long-Term Debt	34.56M	40.65M	40.26M	39.55M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	61.75M	24.47M	3.03M	19.71M	n/a	353K	745K	1.1M
Total Long-Term Liabilities	114.83M	85.97M	66.21M	94.07M	47.28M	8.65M	751K	1.15M
Total Liabilities	151.51M	116.75M	97.72M	122.7M	70.79M	28.18M	13.16M	10.72M
Total Debt	62.08M	63.57M	65.19M	66.21M	25.92M	31K	53K	221K
Common Stock	26K	20K	61K	56K	43K	34K	26K	23K
Retained Earnings	-722.81M	-558.23M	-463.58M	-377.02M	-292.98M	-217.54M	-155.27M	-101.26M
Comprehensive Income	n/a	102K	-79K	0.00	24K	-3K	-42K	-9K
Shareholders Equity	16.66M	127.74M	85.22M	90.55M	79.18M	78.59M	65.32M	80.6M
Total Investments	2.12M	34.84M	51.1M	3.09M	49.98M	49.79M	39.84M	25M